Zynex Elects New Directors at Annual Meeting

Zynex ( (ZYXI) ) has issued an announcement.

On May 15, 2025, Zynex, Inc. held its Annual Meeting of Stockholders in Englewood, Colorado, where key decisions were made regarding the company’s leadership and financial oversight. Thomas Sandgaard, Barry D. Michaels, Michael Cress, and Joshua R. Disbrow were elected as directors, and the appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified, indicating a stable governance structure for the company moving forward.

The most recent analyst rating on (ZYXI) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Zynex stock, see the ZYXI Stock Forecast page.

Spark’s Take on ZYXI Stock

According to Spark, TipRanks’ AI Analyst, ZYXI is a Neutral.

Zynex’s overall stock score reflects its challenging financial position, marked by declining revenues, profitability, and cash flow issues. While technical analysis indicates bearish momentum, the earnings call and corporate events offer some long-term growth potential through product innovation and cost management strategies. However, significant risks remain due to current financial instability and valuation concerns.

To see Spark’s full report on ZYXI stock, click here.

More about Zynex

Zynex, Inc. operates in the medical device industry, focusing on the development and marketing of non-invasive medical devices for pain management and rehabilitation.

Average Trading Volume: 304,350

Technical Sentiment Signal: Sell

Current Market Cap: $65.62M

See more insights into ZYXI stock on TipRanks’ Stock Analysis page.